Document Detail


Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.
MedLine Citation:
PMID:  20835926     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A majority of patients with esophageal cancer present with inoperable disease and require rapid and long-lasting palliation of dysphagia.
STUDY AIM: To compare the duration of relief of dysphagia in patients with inoperable esophageal cancer treated with esophageal stenting alone or a combination of esophageal stenting and external beam radiotherapy (EBRT), and to assess overall survival, treatment-related complications, and quality of life (QOL) in the two groups.
PATIENTS AND METHODS: Patients with inoperable esophageal cancer and with high grade dysphagia were randomized to receive esophageal stenting with self-expandable metal stent (Ultraflex) alone (Group I), versus a combination of stenting followed by EBRT (30 gray in ten divided fractions over 2 weeks) (Group II). Dysphagia relief, overall survival, QOL (using European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30, version 3), and treatment-related complications were assessed in the two groups.
RESULTS: From April 2007 to March 2009, 84 patients were randomized to receive esophageal stent alone (42 patients) or a combination of stent and EBRT (42 patients). The two groups were comparable in demographics, tumor characteristics, indications for palliative treatment, and pretreatment dysphagia score. Dysphagia scores improved significantly in both groups following stent insertion. However, dysphagia relief was more sustained in Group II than in Group I (7 vs. 3 months, p = 0.002). Overall median survival was significantly higher in Group II than in Group I (180 vs. 120 days, p = 0.009). Addition of radiotherapy following stenting prolonged the mean dysphagia-free survival (118.6 ± 55.8 vs. 96.8 ± 43.0 days, p = 0.054). There was significant improvement in all QOL parameters at 1 week after stenting. The QOL, however, significantly declined immediately after radiotherapy. There was no treatment-related mortality, and the incidence of complications was similar in the two groups.
CONCLUSION: Post-stenting EBRT effectively prolongs duration of dysphagia relief and improves overall survival in inoperable esophageal cancer.
Authors:
Amit Javed; Sujoy Pal; Nihar Ranjan Dash; Vineet Ahuja; Bidhu Kalyan Mohanti; Sreenivas Vishnubhatla; Peush Sahni; Tushar Kanti Chattopadhyay
Related Documents :
15713926 - Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents.
16400666 - Endovascular aortic coarctation stenting in adolescents and adults: angiographic and he...
15511446 - Descending thoracic aortic rupture: role of endovascular stent-grafting.
10574396 - Non-elective intra-coronary stenting: are the clinical outcomes comparable to elective ...
2916736 - Screening for cholelithiasis prior to aortic reconstruction.
8174496 - Antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of gastrointestinal cancer     Volume:  43     ISSN:  1941-6636     ISO Abbreviation:  J Gastrointest Cancer     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-28     Completed Date:  2012-06-14     Revised Date:  2012-09-07    
Medline Journal Info:
Nlm Unique ID:  101479627     Medline TA:  J Gastrointest Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  63-9     Citation Subset:  IM    
Affiliation:
Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. javedamitdr@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Deglutition Disorders / therapy*
Esophageal Neoplasms / mortality,  pathology,  psychology,  therapy*
Female
Humans
Male
Middle Aged
Palliative Care*
Prospective Studies
Quality of Life
Stents* / adverse effects

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analy...
Next Document:  Ethics consultation on a gynecologic oncology service: an opportunity for physician education.